Published in Cancer Res on July 01, 1978
Gonadal function after combination chemotherapy for Hodgkin's disease in childhood. Arch Dis Child (1982) 0.94
Role of radiotherapy and chemotherapy in the risk of second malignant neoplasms after cancer in childhood. Br J Cancer (1989) 0.91
Chemically induced leukemia in humans. Environ Health Perspect (1981) 0.86
Chemotherapy and the adult gonad: a review. J R Soc Med (1983) 0.81
Chemical carcinogenesis studies in nonhuman primates. Proc Jpn Acad Ser B Phys Biol Sci (2008) 0.78
Male fertility after VAPEC-B chemotherapy for Hodgkin's disease and non-Hodgkin's lymphoma. Br J Cancer (1994) 0.76
Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol (1996) 21.37
Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum Pathol (1983) 8.24
Recombination and mutation during long-term gastric colonization by Helicobacter pylori: estimates of clock rates, recombination size, and minimal age. Proc Natl Acad Sci U S A (2001) 4.80
Racial differences in survival from breast cancer. Results of the National Cancer Institute Black/White Cancer Survival Study. JAMA (1994) 4.35
Hepatic Helicobacter species identified in bile and gallbladder tissue from Chileans with chronic cholecystitis. Gastroenterology (1998) 4.30
A model for gastric cancer epidemiology. Lancet (1975) 4.02
Transmission of Helicobacter pylori among siblings. Lancet (2000) 3.78
Gastric dysplasia: the Padova international classification. Am J Surg Pathol (2000) 3.66
Preliminary report: isolation of Ebola virus from monkeys imported to USA. Lancet (1990) 3.55
Geographic distribution of vacA allelic types of Helicobacter pylori. Gastroenterology (1999) 3.37
Long term follow up of patients treated for Helicobacter pylori infection. Gut (2005) 3.09
Campylobacter pylori-associated gastritis and immune response in a population at increased risk of gastric carcinoma. Am J Gastroenterol (1989) 2.81
Enzyme immunosorbent assay for Ebola virus antigens in tissues of infected primates. J Clin Microbiol (1992) 2.69
Helicobacter mustelae-associated gastritis in ferrets. An animal model of Helicobacter pylori gastritis in humans. Gastroenterology (1990) 2.64
Inducible nitric oxide synthase, nitrotyrosine, and apoptosis in Helicobacter pylori gastritis: effect of antibiotics and antioxidants. Cancer Res (1996) 2.56
Lung cancer in nonsmoking women: a multicenter case-control study. Cancer Epidemiol Biomarkers Prev (1993) 2.53
Ultrastructure of the gastric mucosa harboring Campylobacter-like organisms. Am J Clin Pathol (1986) 2.52
Transmission of type B viral hepatitis to chimpanzees. J Infect Dis (1973) 2.51
Carcinoma and intestinal metaplasia of the stomach in Colombian migrants. J Natl Cancer Inst (1970) 2.35
Passive smoking and lung cancer. Lancet (1983) 2.27
Protection of monkeys against airborne tuberculosis by aerosol vaccination with bacillus Calmette-Guerin. Am Rev Respir Dis (1973) 2.18
Gastric cancer in Colombia. III. Natural history of precursor lesions. J Natl Cancer Inst (1976) 2.14
The transmission of Helicobacter pylori. A critical review of the evidence. Int J Epidemiol (1995) 2.10
Gastric cancer in Colombia. I. Cancer risk and suspect environmental agents. J Natl Cancer Inst (1976) 2.09
Intestinal metaplasia of human stomach displays distinct patterns of mucin (MUC1, MUC2, MUC5AC, and MUC6) expression. Cancer Res (1999) 2.09
Environmental tobacco smoke and lung cancer in nonsmoking women. A multicenter study. JAMA (1994) 2.04
Long-term feeding of sodium saccharin to nonhuman primates: implications for urinary tract cancer. J Natl Cancer Inst (1998) 2.04
Previous lung disease and risk of lung cancer among lifetime nonsmoking women in the United States. Am J Epidemiol (1995) 2.02
Gastric mucosal atrophy: interobserver consistency using new criteria for classification and grading. Aliment Pharmacol Ther (2002) 1.94
Experimental infection of chimpanzees with the Norwalk agent of epidemic viral gastroenteritis. J Med Virol (1978) 1.84
Helicobacter pylori causes hyperproliferation of the gastric epithelium: pre- and post-eradication indices of proliferating cell nuclear antigen. Am J Gastroenterol (1993) 1.77
Family history of cancer and risk of lung cancer among lifetime nonsmoking women in the United States. Am J Epidemiol (1996) 1.75
Histologic types of gastric carcinoma in high- and low-risk areas. Int J Cancer (1968) 1.73
Breast cancer: factors associated with stage at diagnosis in black and white women. Black/White Cancer Survival Study Group. J Natl Cancer Inst (1993) 1.72
Helicobacter pylori infection in the Colombian Andes: a population-based study of transmission pathways. Am J Epidemiol (1996) 1.69
Precursors of gastric and esophageal cancer. Cancer (1982) 1.65
OLGA staging for gastritis: a tutorial. Dig Liver Dis (2008) 1.64
Effects of long-term oral administration of DDT on nonhuman primates. J Cancer Res Clin Oncol (1999) 1.63
CCL3L1 gene-containing segmental duplications and polymorphisms in CCR5 affect risk of systemic lupus erythaematosus. Ann Rheum Dis (2007) 1.62
Quantitative fluorescence microscopy on single capillaries: alpha-lactalbumin transport. Am J Physiol (1987) 1.61
Evolution of precancerous lesions in a rural Chinese population at high risk of gastric cancer. Int J Cancer (1999) 1.60
Clinical implications of recent developments in gastric cancer pathology and epidemiology. Semin Oncol (1985) 1.59
Gastric dysplasia and gastric cancer: Helicobacter pylori, serum vitamin C, and other risk factors. J Natl Cancer Inst (2000) 1.55
High prevalence and persistence of cytotoxin-positive Helicobacter pylori strains in a population with high prevalence of atrophic gastritis. Am J Gastroenterol (1992) 1.54
Life-style risk factors for pancreatic cancer in Louisiana: a case-control study. Am J Epidemiol (1988) 1.54
Species differences in the aromatization of quinic acid in vivo and the role of gut bacteria. Biochem J (1970) 1.51
Helicobacter pylori genotypes may determine gastric histopathology. Am J Pathol (2001) 1.51
Is gastric carcinoma an infectious disease? N Engl J Med (1991) 1.50
Parathyroid MEN1 gene mutations in relation to clinical characteristics of nonfamilial primary hyperparathyroidism. J Clin Endocrinol Metab (1998) 1.48
Gastric carcinoma in the young. Cancer (1987) 1.47
p53 alteration in gastric precancerous lesions. Am J Pathol (1994) 1.45
Prolonged achlorhydria and gastric neoplasia: is there a causal relationship? Gastroenterology (1993) 1.45
Geographic pathology of latent prostatic carcinoma. Int J Cancer (1982) 1.44
Recommendations on predictive testing for germ line p53 mutations among cancer-prone individuals. J Natl Cancer Inst (1992) 1.43
The impact of vaginal cytology on cervical cancer risks in Cali, Colombia. Int J Cancer (1984) 1.41
Requirement of Rac activity for maintenance of capillary endothelial barrier properties. Am J Physiol Heart Circ Physiol (2003) 1.41
The TPR-MET oncogenic rearrangement is present and expressed in human gastric carcinoma and precursor lesions. Proc Natl Acad Sci U S A (1991) 1.40
Histopathology of gastric dysplasias: correlations with gastric juice chemistry. Am J Surg Pathol (1979) 1.40
Precursor lesions of oesophageal cancer in young people in a high-risk population in China. Lancet (1989) 1.38
Starling forces that oppose filtration after tissue oncotic pressure is increased. Am J Physiol Heart Circ Physiol (2000) 1.35
Toxicity of antineoplastic agents in man, chromosomal aberrations antifertility effects, congenital malformations, and carcinogenic potential. Adv Cancer Res (1975) 1.34
Risk of adenocarcinoma of the stomach and esophagus with meat cooking method and doneness preference. Int J Cancer (1997) 1.32
The metabolic fate of tritiated methotrexate. II. Absorption and excretion in man. Cancer Res (1965) 1.29
Developments in the epidemiology of stomach cancer over the past decade. Cancer Res (1975) 1.26
Morphometric evaluation of gastric antral atrophy: improvement after cure of Helicobacter pylori infection. Am J Gastroenterol (2001) 1.26
Antitumor activity and other biologic properties of L-asparaginase (NSC-109229)-a review. Cancer Chemother Rep (1968) 1.25
CagA C-terminal variations in Helicobacter pylori strains from Colombian patients with gastric precancerous lesions. Clin Microbiol Infect (2009) 1.25
Gastric dysplasia. Significance and pathologic criteria. Cancer (1984) 1.23
Prevalence of latent prostate carcinoma in two U.S. populations. J Natl Cancer Inst (1980) 1.23
The epidemiology of colorectal polyps: prevalence in New Orleans and international comparisons. Cancer (1977) 1.23
Histological characteristics of breast carcinoma in blacks and whites. Cancer Epidemiol Biomarkers Prev (1994) 1.22
Embryotoxic effect of poly I. poly C. Nature (1969) 1.20
Endothelial glycocalyx: permeability barrier and mechanosensor. Ann Biomed Eng (2011) 1.19
Racial differences in tumor grade among women with endometrial cancer. Gynecol Oncol (1995) 1.19
Reduced incidence of gastroduodenal ulcers with celecoxib, a novel cyclooxygenase-2 inhibitor, compared to naproxen in patients with arthritis. Am J Gastroenterol (2001) 1.18
Studies on the antitumor activity, mechanism of action, and cell cycle effects of camptothecin. J Natl Cancer Inst (1971) 1.17
A collaborative study of differences in the survival rates of black patients and white patients with cancer. Cancer (1992) 1.17
The epidemiology and pathogenesis of chronic gastritis: three etiologic entites. Front Gastrointest Res (1980) 1.16
Carcinogenicity of 2-amino-3-methylimidazo[4,5-f]quinoline in nonhuman primates: induction of tumors in three macaques. Jpn J Cancer Res (1990) 1.16
Epidemiologic patterns of Hodgkin's disease. Int J Cancer (1971) 1.15
Cancer of the colon and rectum and adenomatous polyps. A review of epidemiologic findings. Cancer (1971) 1.14
Occupational exposure to environmental tobacco smoke. JAMA (1996) 1.13
Risk factors for maternal mortality: a case-control study in Dakar hospitals (Senegal). Afr J Reprod Health (1997) 1.13
Gastric cancer in Colombia. IV. Nitrite and other ions in gastric contents of residents from a high-risk region. J Natl Cancer Inst (1979) 1.12
Monoclonal antibodies in the lymphatics: selective delivery to lymph node metastases of a solid tumor. Science (1983) 1.12
Dietary determinants of gastric cancer in south Louisiana inhabitants. J Natl Cancer Inst (1985) 1.12
Epidemiological correlations between diet and cancer frequency. Cancer Res (1981) 1.12
Tumor incidence in a chemical carcinogenesis study of nonhuman primates. Regul Toxicol Pharmacol (1994) 1.11
Serum pepsinogens as markers of response to therapy for Helicobacter pylori gastritis. Dig Dis Sci (1993) 1.10
The epidemiology of large-bowel cancer. Adv Cancer Res (1978) 1.10
Epidemiological evidence for the role of nitroso compounds in human cancer. Cancer Surv (1989) 1.10
cAMP protects endothelial barrier functions by preventing Rac-1 inhibition. Am J Physiol Heart Circ Physiol (2004) 1.10
Helicobacter pylori antibodies in relation to precancerous gastric lesions in a high-risk Chinese population. Cancer Epidemiol Biomarkers Prev (1996) 1.10
Helicobacter pylori and gastric atrophy--cancer paradoxes. J Natl Cancer Inst (1995) 1.09